Anagrelide vs. Hydroxyurea - Efficacy and Tolerability Study in Patients With Essential Thrombocythaemia
Clinical trial NCT01065038 · COMPLETED
Trial details
- NCT number
- NCT01065038
- Sponsor
- AOP Orphan Pharmaceuticals AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.